Liqing Wei

Liqing Wei

Auto-generated profile, based on publicly available information

Liqing Wei

Wuhan Wuchang Hospital, Wuhan University of Science and Technology, Wuhan, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Gene
Verified
Journal Article
Closed access
YCYi-Zhi Cao
Yi-Zhi Cao
JSJinyu Sun
Jinyu Sun
YCYan-Xiang Chen
Yan-Xiang Chen
CWCheng-Cai Wen
Cheng-Cai Wen
LWLiqing Wei
Liqing Wei

1 December 2020 in Gene
Verified
Journal Article
Closed access
JLJianping Li
Jianping Li
FZFeng Zhang
Feng Zhang
HLHaohuan Li
Haohuan Li
FPFei Peng
Fei Peng
ZWZhe Wang
Zhe Wang
LWLiqing Wei
Liqing Wei

22 June 2021 in International Journal of Environmental Health Research
Verified
Journal Article
Closed access
MGMenglan Guo
Menglan Guo
LWLiqing Wei
Liqing Wei
HYHong Yan
Hong Yan
ZDZhizhou Duan
Zhizhou Duan
Zhiping NiuZhiping Niu
Zhiping Niu
CXChenchang Xiao
Chenchang Xiao
The study explored the associations between maternal exposure to air pollution during different trimesters and allergic diseases including asthma, allergic rhinitis, allergic conjunctivitis or/and eczema. Individual exposure to air pollutants was assessed by an inverse distance weighted (IDW) method using daily concentrations of SO2, NO2, PM10, and PM2.5 from air quality monitoring stations. Multiple logistic regression model was performed to estimate the associations between air pollution during each trimester of pregnancy and childhood allergic diseases. A total of 332 children (51.3%) were reported by their parents having been diagnosed with allergic diseases. After adjusting for covariates, allergic diseases were significantly associated with per interquartile range (IQR) increase in NO2, PM10, PM2.5 during the second trimester with odds ratios (ORs) and 95% confidence intervals (95%CIs) being 1.292 (1.005,1.662), 1.210 (1.042,1,405) and 1.270 (1.004,1.606), respectively. These findings suggest that maternal exposure to certain air pollutants during pregnancy, especially in the second trimester, is associated with childhood allergic diseases.

1 January 2021 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
PDF file
ZLZhenzhao Luo
Zhenzhao Luo
YFYue Fan
Yue Fan
XLXianchang Liu
Xianchang Liu
SLShuiyi Liu
Shuiyi Liu
XKXiaoyu Kong
Xiaoyu Kong
LWLiqing Wei
Liqing Wei
Background: Previous studies reported that N-myc downstream-regulated gene 1 (NDRG1) was upregulated in various cancer tissues and decreased expression of miR-188-3p and miR-133b could suppress cell proliferation, metastasis, and invasion and induce apoptosis of cancer cells. However, the molecular mechanism of NRDG1 involved in hepatocellular carcinoma (HCC) tumorigenesis is still unknown. Methods: The expressions of miR-188-3p, miR-133b, and NRDG1 in HCC tissues and cells were quantified by qRT-PCR and Western blot. MTT assay and transwell invasion assay were performed to evaluate cell growth and cell migration, respectively. Luciferase reporter assay were performed to determine whether miR-188-3p and miR-133b could directly bind to NRDG1 in HCC cells. Results: The results showed that NRDG1 was upregulated and these 2 microRNAs were downregulated in HCC tissues. NRDG1 was negatively correlated with miR-188-3p and miR-133b in HCC tissues. MiR-188-3p and miR-133b were demonstrated to directly bind to 3′UTR of NRDG1 and inhibit its expression. Upregulation of miR-188-3p and miR-133b reduced NRDG1 expression in hepatocellular carcinoma cell lines, which consequently inhibited cell growth and cell migration. Conclusions: Our finding suggested that miR-188-3p and miR-133b exert a suppressive effect on hepatocellular carcinoma proliferation, invasion, and migration through downregulation of NDRG1.

5 June 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
YQYuwen Qi
Yuwen Qi
YLYing Li
Ying Li
HWHua Wang
Hua Wang
AWAnjin Wang
Anjin Wang
XLXuelian Liu
Xuelian Liu
LWLiqing Wei
Liqing Wei
Chimeric antigen receptor‐ (CAR‐)modified T cells have been successfully used to treat blood cancer. With the improved research on anti‐tumour adoptive cell therapy, researchers have focused on immune cells other than T lymphocytes. Natural killer (NK) cells have received widespread attention as barriers to natural immunity. Compared to T lymphocyte‐related adoptive cell therapy, the use of NK cells to treat tumours does not cause graft‐versus‐host disease, significantly improving immunity. Moreover, NK cells have more sources than T cells, and the related modified cells are less expensive. NK cells function through several pathways in anti‐tumour mechanisms. Currently, many anti‐tumour clinical trials have used NK cell‐related adoptive cell therapies. In this review, we have summarized the recent progress in NK cell‐related adoptive cellular immunotherapy for tumour treatment and propose the current challenges faced by CAR‐NK cell therapy.

1 October 2021 in Child Abuse & Neglect
Verified
Journal Article
Closed access
XLXiaoyan Li
Xiaoyan Li
MGMenglan Guo
Menglan Guo
Wei WangWei Wang
Wei Wang
LWLiqing Wei
Liqing Wei
CXChenchang Xiao
Chenchang Xiao
HYHong Yan
Hong Yan